Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cannabis cream is an investigational topical formulation containing a full-spectrum cannabis extract with a balanced 1:1:1 ratio of cannabidiol (CBD), tetrahydrocannabinol (THC), and cannabigerol (CBG) at a concentration of 20 mg/ml. Developed by the Federal University of Latin American Integration (UNILA) in collaboration with the Santa Cannabis association, this topical therapy is being evaluated in the CBDermis clinical trial for the treatment of mild to moderate psoriasis vulgaris. The cream aims to alleviate localized skin symptoms such as inflammation, pruritus, and scaling by targeting the endocannabinoid system in the skin, while also being studied in combination with an oral cannabis oil to address both physical and psychosocial aspects of the disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cannabis cream.